Benefits
Screen-related eye fatigue
Heat-killed KW3110 taken daily for 8 weeks was tested in small trials for eye fatigue brought on by prolonged screen (visual display terminal) use.
Eye comfort during screen use
The trials measured critical flicker frequency, a marker of eye fatigue. Effects were modest, and for the primary endpoint of one trial the benefit appeared only in a subgroup with high baseline fatigue.
How it is thought to work
KW3110 acts as an immune-modulating, anti-inflammatory postbiotic and raises regulatory signals such as interleukin-10 in laboratory models. These are mechanisms, not measured clinical outcomes, and no skin benefit has been tested in people.
Mechanism of action
Immune modulation
KW3110 stimulates immune cells to release regulatory cytokines such as interleukin-10, which may temper inflammatory stress in retinal cells exposed to blue light in laboratory models.
Anti-inflammatory action
By dampening inflammatory signaling, the postbiotic is proposed to reduce blue-light-driven stress on retinal pigment epithelium cells; this is shown in cell and animal models, not as a clinical outcome in people.
Clinical trials
Randomized, double-blind, placebo-controlled trial of heat-killed L. paracasei KW3110 on eye fatigue from visual display terminal (screen) use over 8 weeks. (Morita et al. 2018, Nutrients)
62 healthy Japanese adults aged 35 to 45 with screen-related eye fatigue.
Critical flicker frequency, a marker of eye fatigue, tended to decline less in the KW3110 group; the difference reached significance only in a subgroup with high baseline eye fatigue at week 4. The manufacturer, Kirin, funded the study.